Preview Mode Links will not work in preview mode

Through personal stories and interviews with experts, we expose the true scope of migraine by exploring symptoms, treatments, research topics and more.

Formerly known as Shades of Migraine.


Mar 7, 2023

Atogepant is FDA approved for the prevention of episodic migraine, and is under review for the prevention of chronic migraine at the time of publication. Stay tuned as Dr. Cynthia E. Armand discusses the goals of migraine prevention, atogepant clinical trial data, how it compares to other gepant medications, side...